- Home
- KROS vs EMO Comparison
KROS vs EMO Comparison
Compare KROS & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- EMO
- Stock Information
- Founded
- KROS 2015
- EMO 2011
- Country
- KROS United States
- EMO United States
- Employees
- KROS N/A
- EMO N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- EMO Investment Managers
- Sector
- KROS Health Care
- EMO Finance
- Exchange
- KROS Nasdaq
- EMO Nasdaq
- Market Cap
- KROS 558.9M
- EMO 837.1M
- IPO Year
- KROS 2020
- EMO N/A
- Fundamental
- Price
- KROS $14.53
- EMO $47.37
- Analyst Decision
- KROS Buy
- EMO
- Analyst Count
- KROS 13
- EMO 0
- Target Price
- KROS $20.63
- EMO N/A
- AVG Volume (30 Days)
- KROS 477.3K
- EMO 27.1K
- Earning Date
- KROS 08-06-2025
- EMO 01-01-0001
- Dividend Yield
- KROS N/A
- EMO 6.70%
- EPS Growth
- KROS N/A
- EMO N/A
- EPS
- KROS 0.11
- EMO N/A
- Revenue
- KROS $214,713,000.00
- EMO N/A
- Revenue This Year
- KROS $5,006.76
- EMO N/A
- Revenue Next Year
- KROS N/A
- EMO N/A
- P/E Ratio
- KROS $132.80
- EMO N/A
- Revenue Growth
- KROS 91657.70
- EMO N/A
- 52 Week Low
- KROS $9.12
- EMO $26.42
- 52 Week High
- KROS $72.37
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- KROS 64.67
- EMO 55.51
- Support Level
- KROS $13.26
- EMO $46.70
- Resistance Level
- KROS $14.68
- EMO $47.66
- Average True Range (ATR)
- KROS 0.41
- EMO 0.75
- MACD
- KROS 0.12
- EMO -0.00
- Stochastic Oscillator
- KROS 89.35
- EMO 61.33
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.